Pricing Committee To Support Pharmaceutical Market Growth In Ghana
Pharma & Healthcare / Ghana / Mon 08 Jul, 2019
Key View
- The actions of the National Medicine Price Committee will primarily benefit individual patients and institutional payers.
- It will also provide some benefits to pharmaceutical companies operating in the country.
- A cap on patented drug prices will however not be welcomed by foreign multinationals.
- Drugmakers should be aware that the